Lataa...

Regulation of CD20 in rituximab-resistant cell lines (RRCL) and B-cell non-Hodgkin lymphoma (B-NHL)

PURPOSE: The aim of this research was to further investigate the contribution of CD20 antigen expression to rituximab activity and define the mechanisms responsible for CD20 downregulation in rituximab-resistant cell lines (RRCL). EXPERIMENTAL DESIGN: Rituximab-sensitive, rituximab-resistant cell li...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Tsai, Ping-Chiao, Hernandez-Ilizaliturri, Francisco J., Bangia, Naveen, Olejniczak, Scott, Czuczman, Myron S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3288324/
https://ncbi.nlm.nih.gov/pubmed/22228637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-1429
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!